Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 21, 2011

Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.

View Full Paper
Ask AI
Bookmark
Share

Authors

HNHelmut NeumannJohannes Gutenberg University MainzMVMichael ViethUniversity of LeedsCLCord LangnerMedical University of Graz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Neumann et al. (2011) studied this question.

synapsesocial.com/papers/69d820f83eff0c9dfaae37e7https://doi.org/10.3748/wjg.v17.i27.3184
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer2008 · 109 citations
  2. 2Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance2007 · 439 citations
  3. 3Genetic Alterations in Chronic Ulcerative Colitis-Associated Adenoma-Like DALMs Are Similar to Non-Colitic Sporadic Adenomas2000 · 85 citations